Tuesday, November 24, 2015

Imprimis Pharmaceuticals Sees Unusually-High Trading Volume ... Putnam Standard-15 hours ago

Imprimis Pharmaceuticals Sees Unusually-High Trading Volume ...

Putnam Standard-15 hours ago
The Company focuses on developing and commercializing compounded drugtherapies and making these therapies available to physicians and patients

No comments: